Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity

C-MET as a new therapeutic target for the development of novel anticancer drugs

(2010) Israel Cañadas et al.   Clinical & Translational Oncology

Emerging therapies for the treatment of relapsed or refractory multiple myeloma

(2010) Meletios A. Dimopoulos et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

(2010) S Whittaker et al.   ONCOGENE

Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

(2009) D. W. McMillin et al.   CANCER RESEARCH

Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation

(2009) Lindsey A. Allan et al.   FEBS Journal

Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy

(2009) Y. Li et al.   MOLECULAR CANCER THERAPEUTICS

Hepatocyte growth factor promotes migration of human myeloma cells

(2008) R. U. Holt et al.   HAEMATOLOGICA